GURUFOCUS.COM » STOCK LIST » Basic Materials » Metals & Mining » Crism Therapeutics Corp (LSE:CRTX) » Definitions » Deferred Policy Acquisition Costs

Crism Therapeutics (LSE:CRTX) Deferred Policy Acquisition Costs


View and export this data going back to 2006. Start your Free Trial

What is Crism Therapeutics Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Crism Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
Kingston Chambers, P.O. Box 173, Tortola, Road Town, VGB
Crism Therapeutics Corp has developed a drug delivery technology to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs. Its product ChemoSeed which is in its clinical trial phase, can be implanted directly into the tumour or the resection margin following the removal of a tumour. The company also provides consultancy and formulation services to its clients assisting them with pharmaceutical formulation and development.